StockData
EoCene Ltd. logo

EoCene Ltd. (EOCN) stock

EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 31, 2026Score 5/30
$2.20−0.26 (-10.63%)

Close on Nov 18, 2026Market cap $2.20MP/E –Yield –

EoCene shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

EoCene's shares outstanding was 1M at Jun 30, 2026. For fiscal 2025 it was 1M, up 363.2% from the year before. Over ten years it grew 52.9% a year on average. The highest annual figure on record is 1M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20251M+363.2%
FY2024Dec 31, 20240M+303.3%
FY2023Dec 31, 20230M+65.2%
FY2022Dec 31, 20220M+2.2%
FY2021Dec 31, 20210M+15.6%
FY2020Dec 31, 20200M+0.8%
FY2019Dec 31, 20190M+16.4%
FY2018Dec 31, 20180M+45.2%
FY2017Dec 31, 20170M+9.8%
FY2016Dec 31, 20160M+2.5%
FY2015Dec 31, 20150M+7.5%
FY2014Dec 31, 20140M+103.7%
FY2013Dec 31, 20130M+2.3%
FY2012Dec 31, 20120M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20261M+374.0%
Q4 FY2025Dec 31, 20251M+625.2%
Q3 FY2025Sep 30, 20251M+705.5%
Q2 FY2025Jun 30, 20250M+2719.8%
Q4 FY2024Dec 31, 20240M+1052.9%
Q3 FY2024Sep 30, 20240M+495.3%
Q2 FY2024Jun 30, 20240M+476.8%
Q2 FY2023Jun 30, 20230M+19.3%
Q2 FY2022Jun 30, 20220M+59.7%
Q2 FY2021Jun 30, 20210M+106.0%
Q2 FY2020Jun 30, 20200M+90.6%
Q2 FY2019Jun 30, 20190M+90.3%
Q2 FY2018Jun 30, 20180M–
Q2 FY2017Jun 30, 20170M–
Q2 FY2016Jun 30, 20160M–
Q2 FY2015Jun 30, 20150M–

More EoCene figures

See a number that looks wrong?